Symptomatic Hand Osteoarthritis in the United States: Prevalence and Functional Impairment Estimates from the Third U.S. National Health and Nutrition Examination Survey, 1991-1994
Overview
Affiliations
Objective: To estimate the United States prevalence of symptomatic hand osteoarthritis using American College of Rheumatology (ACR) physical examination criteria.
Design: The Third National Health and Nutrition Examination Survey (NHANES III), a nationally representative cross-sectional health examination survey, performed upper-extremity physical examinations on a sample of United States adults age 60+ yrs. Data for demographics, pain history, analgesic use, and activity limitations were obtained by interview.
Results: Among United States adults, 58% had Heberden's nodes, 29.9% had Bouchard's nodes, and 18.2% had first carpal-metacarpal deformities. Women had significantly more first carpal-metacarpal deformities (24.3%) than men (10.3%). Symptomatic osteoarthritis prevalence at these sites was 5.4, 4.7, and 1.9%, respectively. Overall, symptomatic hand osteoarthritis prevalence by ACR criteria was 8% (95% CI 6.5-9.5%), or 2.9 million persons. Symptomatic hand osteoarthritis significantly increased with age and was decreased among non-Hispanic blacks, but there were no gender differences. Symptomatic hand osteoarthritis was associated with self-reported difficulty lifting 10 lbs (OR 2.31; 95% CI 1.23-4.33), dressing (OR 3.77; 95% CI 1.99-7.13), and eating (OR 3.44; 95% CI 1.76-6.73). Frequent monthly use was significantly increased for analgesics, especially acetaminophen, but not nonsteroidal antiinflammatory drugs.
Conclusion: Symptomatic hand osteoarthritis affects 1 in 12 older United States adults. NHANES III data provide a population-based assessment of the impact and associated functional impairments of symptomatic hand osteoarthritis.
Levey N, Chen N, Ditre J, Sylvia L, Mudgal C, Bhashyam A JMIR Res Protoc. 2024; 13:e64547.
PMID: 39652859 PMC: 11667126. DOI: 10.2196/64547.
Tagoe C, Wang W, Kwon H Front Med (Lausanne). 2024; 11:1445188.
PMID: 39228802 PMC: 11368861. DOI: 10.3389/fmed.2024.1445188.
Saito S, Makino A, Morimoto N Heliyon. 2024; 10(12):e32830.
PMID: 38975115 PMC: 11226916. DOI: 10.1016/j.heliyon.2024.e32830.
Moglia A, Marsilio L, Rossi M, Pinelli M, Lettieri E, Mainardi L IEEE J Transl Eng Health Med. 2024; 12:279-290.
PMID: 38410183 PMC: 10896423. DOI: 10.1109/JTEHM.2023.3335608.
Ikumi A, Yoshii Y, Kohyama S, Iwabuchi S, Mammoto T, Ogawa T Cureus. 2024; 16(1):e52025.
PMID: 38344617 PMC: 10855007. DOI: 10.7759/cureus.52025.